People_

Dr Narcyz Ghinea

Senior Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health

Email

narcyz.ghinea@sydney.edu.au

Narcyz Ghinea is a leading researcher investigating how institutional drivers influence patient access to medications and other health services. His work focuses on overcoming the legal, policy, and political barriers that impede access to health technologies and generate systemic inequities.

Research interests

Areas of research focus include therapeutic goods regulation, health technology assessment, medical negligence law, professional duties, medical epistemology, and commercial determinants of health.

Themes

Cancer

Keywords

Biomedical ethics, Health inequalities, Health policy, Medical sociology, Pharmaceutical

Approaches

Ethics, Qualitative Research, Theory Generation

Publications

By Type

Expand all

Book Chapters

Lipworth, W., Wiersma, M., Ghinea, N., Hendly, T., Kerridge, I., Lysaght, T., Munsie, M., Rudge, C., Stewart, C., Waldby, C. (2021). The Oversight of Clinical Innovation in a Medical Marketplace. In Graeme Laurie, Edward Dove, Agomoni Ganguli-Mitra, Catriona McMillan et al (Eds.), The Cambridge Handbook of Health Research Regulation, (pp. 287-295). Cambridge: Cambridge University Press. [More Information]
Pace, J., Ghinea, N., Wiersma, M., Morrell, B., Kerridge, I., Lipworth, W. (2019). Clinical Quandaries Associated With Accelerated Access to Medicines. In Kathleen Montgomery, Wendy Lipworth (Eds.), Medical Professionals: Conflicts and Quandaries in Medical Practice, (pp. 48-66). New York: Routledge. [More Information]
Ghinea, N., Kerridge, I., Lipworth, W. (2019). Off-Label Prescribing: The Borderlands Between Clinical Practice and Experimentation. In Kathleen Montgomery, Wendy Lipworth (Eds.), Medical Professionals: Conflicts and Quandaries in Medical Practice, (pp. 28-47). New York: Routledge. [More Information]

Journals

Ghinea, N. (2024). A physician’s identity can never be reconfigured to put climate protection on par with an individual patient's best interests. Journal of Medical Ethics, 50(6), 375. [More Information]
Ghinea, N. (2024). Aligning legislation with clinical practice: off-label prescribing under the microscope. Medical Journal of Australia, 221(8), 417-419. [More Information]
Ghinea, N. (2024). An Analysis of Australia’s Legal Framework for Access to More Affordable but Unapproved Medicines and Biologics. Journal of Bioethical Inquiry. [More Information]
Ghinea, N. (2024). Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context. Medical Journal of Australia, 221(8), 414-416. [More Information]
Ghinea, N., Hutchison, K., Lotz, M., Rogers, W. (2024). Cost-Related Non-Adherence to Prescribed Medicines: What Are Physicians' Moral Duties? The American Journal of Bioethics. [More Information]
Stanbury, C., Kerridge, I., Newson, A., Ghinea, N., Lipworth, W. (2024). Do Doctors Have a Responsibility to Challenge the Distorting Influence of Commerce on Healthcare Delivery? The Case of Assisted Reproductive Technology. Health Care Analysis. [More Information]
Ghinea, N. (2024). The increasing costs of medicines and their implications for patients, physicians and the health system. Internal Medicine Journal, 54(4), 545-550. [More Information]
Ghinea, N. (2024). The Medicines Repurposing Program – a critical perspective. Australian Health Review, 48(3), 259-261. [More Information]
Melman, A., Vella, S., Dodd, R., Coombs, D., Richards, B., Rogan, E., Teng, M., Maher, C., Ghinea, N., De Carvalho Machado, G. (2023). Clinicians' Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study. JMIR Rehabilitation and Assistive Technologies, 10, e47227-e47227. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I., Zalcberg, J. (2023). How therapeutic advances have transformed the medical landscape: a primer for clinicians. Internal Medicine Journal, 53(8), 1306-1310. [More Information]
Ghinea, N. (2023). Physicians' legal duty to disclose more cost-effective treatment options: an examination of Australian civil law applied to personal importation. Australian Health Review, 47(3), 314-321. [More Information]
Rudge, C., Ghinea, N. (2023). Promoting the personal importation of therapeutic goods: recent legislative amendments to advertising regulations may impact consumer access and understanding. Australian Health Review, 47(2), 182-191. [More Information]
Ghinea, N., Roberts, A., Prvan, T., Rogers, W. (2023). The incidence of personal importation of prescription medicines among Australians 45 and older: a cross-sectional survey. Australian Health Review, 47(6), 694-699. [More Information]
Ghinea, N. (2023). What about the reasonableness of patients’ risk attitudes? A challenge to Makins’ antipaternalistic account. Journal of Medical Ethics, 49(11), 751-752. [More Information]
Ghinea, N. (2023). ‘First ensure no regret’: a decision-theoretic approach to informed consent in clinical practice. Journal of Medical Ethics. [More Information]
Ghinea, N. (2022). Do doctors have a responsibility to help patients import medicines from abroad? Journal of Medical Ethics, 49(2), 131-135. [More Information]
Ghinea, N., Sheahan, L., Kerridge, I. (2022). Ethics Consultation Services as a Resource and its Implications for Evaluation Activities. The American Journal of Bioethics, 22(4), 59-60. [More Information]
Ghinea, N. (2022). Personal Importation and the Law: Protecting Patients Who Import Medicines for Legitimate Health Care Needs. Journal of Law and Medicine, 29(3), 829-846.
Ghinea, N., Wiersma, M., Newson, A., Walby, C., Norman, R., Lipworth, W. (2022). Situating commercialization of assisted reproduction in its socio-political context: A critical interpretive synthesis. Human Reproduction Open, 2022 (4). [More Information]
Ghinea, N., Critchley, C., Morrell, B., Kerridge, I., Campbell, T., Day, R., Gazarian, M., Isaacs, D., Liauw, W., Olver, I., Pace, J., Pearson, S., Lipworth, W., et al (2021). A survey of Australian public attitudes towards funding of high cost cancer medicines. Health Policy, 125(3), 327-334. [More Information]
Ghinea, N., Wiersma, M., Kerridge, I., Lipworth, W. (2021). Are my religious beliefs anyone's business? A framework for declarations in health and biomedicine. Journal of Medical Ethics, 47(12), 803-806. [More Information]
Pace, J., Ghinea, N., Pearson, S., Kerridge, I., Lipworth, W. (2021). Consumer perspectives of accelerated access to medicines: a qualitative study. Journal of Health Organization and Management, 35(8), 987-1007. [More Information]
Rudge, C., Ghinea, N., Munsie, M., Stewart, C. (2021). Regulating autologous stem cell interventions in Australia: Updated review of the direct-to-consumer advertising restrictions. Australian Health Review, 45(4), 507-515. [More Information]
Ghinea, N., Wiersma, M., Kerridge, I., Olver, I., Pearson, S., Day, R., Liauw, W., Lipworth, W. (2020). "Some sort of fantasy land": A qualitative investigation of appropriate prescribing in cancer care. Journal of Evaluation in Clinical Practice, 26(3), 747-754. [More Information]
Ghinea, N. (2020). A return to reasonableness and virtue in medical epistemology. Journal of Evaluation in Clinical Practice, 26(2), 447-451. [More Information]
Ghinea, N., Munsie, M., Rudge, C., Stewart, C. (2020). Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. Regenerative Medicine, 15(2), 1361-1369. [More Information]
Skowronski, G., O'Leary, M., Critchley, C., O'Reilly, L., Forlini, C., Ghinea, N., Sheahan, L., Stewart, C., Kerridge, I. (2020). Death, dying and donation: Community perceptions of brain death and their relationship to decisions regarding withdrawal of vital organ support and organ donation. Internal Medicine Journal, 50, 1192-1201. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2020). Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity? Journal of Bioethical Inquiry, 17(1), 87-94. [More Information]
De Carvalho Machado, G., Ghinea, N., Rogan, E., Day, R., Maher, C. (2020). Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines? EMA - Emergency Medicine Australasia, 32(5), 890-892. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2020). Lead Essay: Money, Equity and Access to Medicines. Journal of Bioethical Inquiry, 17(1), 25-27. [More Information]
Stewart, C., Kerridge, I., Waldby, C., Lipworth, W., Munsie, M., Lysaght, T., Rudge, C., Ghinea, N., Eckstein, L., Neilsen, J., et al (2020). Unconventional Practice, "Innovative" Interventions and the National Law. Journal of Law and Medicine, 27(3), 574-589.
Ghinea, N. (2019). Citizen Science and the Politicization of Epistemology. The American Journal of Bioethics, 19(8), 58-60. [More Information]
Lipworth, W., Ghinea, N., Kerridge, I. (2019). Clarifying the Relationship Between Serious Ethical Violations and Conflicts of Interest. The American Journal of Bioethics, 19(1), 48-50. [More Information]
Lipworth, W., Kerridge, I., Ghinea, N., Zalcberg, J. (2019). Clearing the air: towards agreement about access to high cost cancer medicines. Annals of Oncology, 30(1), 143-146. [More Information]
Day, R., Cohen, M., Coleshill, M., Ghinea, N., Lipworth, W., Maher, C., Latimer, J., Lin, C., McLachlan, A. (2019). Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis? The Lancet, 1, e142. [More Information]
Wiersma, M., Ghinea, N., Lipworth, W. (2019). Limiting religious contributions - a response to Schuklenk. Developing World Bioethics, 19(3), 126-127. [More Information]
Wiersma, M., Ghinea, N., Kerridge, I., Lipworth, W. (2019). ‘Treat them into the grave’: cancer physicians’ attitudes towards the use of high-cost cancer medicines at the end of life. Sociology of Health & Illness, 41(2), 343-359. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2018). An ethical framework for the creation, governance and evaluation of accelerated access programs. Health Policy, 122(9), 984-990. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Accelerated Access to Medicines: An Ethical Analysis. Therapeutic Innovation and Regulatory Science, 51(2), 157-163. [More Information]
Ghinea, N., Little, M., Lipworth, W. (2017). Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake. Journal of Bioethical Inquiry, 14(3), 401-410. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Caution needed in introduction of provisional approvals for medicines. Internal Medicine Journal, 47(11), 1321-1324. [More Information]
Ghinea, N., Kerridge, I., Little, M., Lipworth, W. (2017). Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribing. Journal of Evaluation in Clinical Practice, 23(3), 574-581. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Demands for access to new therapies: Are there alternatives to accelerated access? BMJ, 359, 1-4. [More Information]
Ghinea, N., Lipworth, W., Day, R., Hill, A., Dore, G., Danta, M. (2017). Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries. The Lancet, 389(10075), 1268-1272. [More Information]
Danta, M., Ghinea, N. (2017). The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study. Journal of Virus Eradication, 3(2), 77-81.
Harper, C., Ghinea, N., Lipworth, W. (2017). The Right to Health: Implications for the Funding of Medicines in Australia. Journal of Law and Medicine, 24(3), 640-655.
Ghinea, N., Lipworth, W. (2016). Affordable access to innovative cancer medicines - don't forget the prices. Medical Journal of Australia, 204(6), 214-215.e1. [More Information]
Lipworth, W., Ghinea, N., Kerridge, I. (2016). Negotiating limits to the funding of high cost cancer medicines. Cancer Forum, 40(2), 93-96. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2016). Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ, 352, 1-4. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2015). Evidence, regulation and 'rational' prescribing: The case of gabapentin for neuropathic pain. Journal of Evaluation in Clinical Practice, 21(1), 28-33. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2015). Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable? Therapeutic Innovation and Regulatory Science, 49(3), 359-363. [More Information]
Ghinea, N., Lipworth, W., Little, J., Kerridge, I., Day, R. (2015). Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage. Developing World Bioethics, 15(1), 48-54. [More Information]
Day, R., Lipworth, W., Ghinea, N. (2015). The Ethics Around Drug Labels and Generic Medicines. Therapeutic Innovation and Regulatory Science, 49(3), 348-351. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I., Little, J., Day, R. (2014). Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. The Hastings Center Report, 44(2), 38-45. [More Information]
Ghinea, N., Ghinea, N., Lipworth, W., Lipworth, W., Kerridge, I., Kerridge, I., Day, R., Day, R. (2012). No evidence or no alternative? Taking responsibility for off-label prescribing. Internal Medicine Journal, 42(3), 247-251. [More Information]

show 52 more

By Year

Expand all

2024

Ghinea, N. (2024). A physician’s identity can never be reconfigured to put climate protection on par with an individual patient's best interests. Journal of Medical Ethics, 50(6), 375. [More Information]
Ghinea, N. (2024). Aligning legislation with clinical practice: off-label prescribing under the microscope. Medical Journal of Australia, 221(8), 417-419. [More Information]
Ghinea, N. (2024). An Analysis of Australia’s Legal Framework for Access to More Affordable but Unapproved Medicines and Biologics. Journal of Bioethical Inquiry. [More Information]
Ghinea, N. (2024). Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context. Medical Journal of Australia, 221(8), 414-416. [More Information]
Ghinea, N., Hutchison, K., Lotz, M., Rogers, W. (2024). Cost-Related Non-Adherence to Prescribed Medicines: What Are Physicians' Moral Duties? The American Journal of Bioethics. [More Information]
Stanbury, C., Kerridge, I., Newson, A., Ghinea, N., Lipworth, W. (2024). Do Doctors Have a Responsibility to Challenge the Distorting Influence of Commerce on Healthcare Delivery? The Case of Assisted Reproductive Technology. Health Care Analysis. [More Information]
Ghinea, N. (2024). The increasing costs of medicines and their implications for patients, physicians and the health system. Internal Medicine Journal, 54(4), 545-550. [More Information]
Ghinea, N. (2024). The Medicines Repurposing Program – a critical perspective. Australian Health Review, 48(3), 259-261. [More Information]

show 5 more

2023

Melman, A., Vella, S., Dodd, R., Coombs, D., Richards, B., Rogan, E., Teng, M., Maher, C., Ghinea, N., De Carvalho Machado, G. (2023). Clinicians' Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study. JMIR Rehabilitation and Assistive Technologies, 10, e47227-e47227. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I., Zalcberg, J. (2023). How therapeutic advances have transformed the medical landscape: a primer for clinicians. Internal Medicine Journal, 53(8), 1306-1310. [More Information]
Ghinea, N. (2023). Physicians' legal duty to disclose more cost-effective treatment options: an examination of Australian civil law applied to personal importation. Australian Health Review, 47(3), 314-321. [More Information]
Rudge, C., Ghinea, N. (2023). Promoting the personal importation of therapeutic goods: recent legislative amendments to advertising regulations may impact consumer access and understanding. Australian Health Review, 47(2), 182-191. [More Information]
Ghinea, N., Roberts, A., Prvan, T., Rogers, W. (2023). The incidence of personal importation of prescription medicines among Australians 45 and older: a cross-sectional survey. Australian Health Review, 47(6), 694-699. [More Information]
Ghinea, N. (2023). What about the reasonableness of patients’ risk attitudes? A challenge to Makins’ antipaternalistic account. Journal of Medical Ethics, 49(11), 751-752. [More Information]
Ghinea, N. (2023). ‘First ensure no regret’: a decision-theoretic approach to informed consent in clinical practice. Journal of Medical Ethics. [More Information]

show 4 more

2022

Ghinea, N. (2022). Do doctors have a responsibility to help patients import medicines from abroad? Journal of Medical Ethics, 49(2), 131-135. [More Information]
Ghinea, N., Sheahan, L., Kerridge, I. (2022). Ethics Consultation Services as a Resource and its Implications for Evaluation Activities. The American Journal of Bioethics, 22(4), 59-60. [More Information]
Ghinea, N. (2022). Personal Importation and the Law: Protecting Patients Who Import Medicines for Legitimate Health Care Needs. Journal of Law and Medicine, 29(3), 829-846.
Ghinea, N., Wiersma, M., Newson, A., Walby, C., Norman, R., Lipworth, W. (2022). Situating commercialization of assisted reproduction in its socio-political context: A critical interpretive synthesis. Human Reproduction Open, 2022 (4). [More Information]

show 1 more

2021

Ghinea, N., Critchley, C., Morrell, B., Kerridge, I., Campbell, T., Day, R., Gazarian, M., Isaacs, D., Liauw, W., Olver, I., Pace, J., Pearson, S., Lipworth, W., et al (2021). A survey of Australian public attitudes towards funding of high cost cancer medicines. Health Policy, 125(3), 327-334. [More Information]
Ghinea, N., Wiersma, M., Kerridge, I., Lipworth, W. (2021). Are my religious beliefs anyone's business? A framework for declarations in health and biomedicine. Journal of Medical Ethics, 47(12), 803-806. [More Information]
Pace, J., Ghinea, N., Pearson, S., Kerridge, I., Lipworth, W. (2021). Consumer perspectives of accelerated access to medicines: a qualitative study. Journal of Health Organization and Management, 35(8), 987-1007. [More Information]
Rudge, C., Ghinea, N., Munsie, M., Stewart, C. (2021). Regulating autologous stem cell interventions in Australia: Updated review of the direct-to-consumer advertising restrictions. Australian Health Review, 45(4), 507-515. [More Information]
Lipworth, W., Wiersma, M., Ghinea, N., Hendly, T., Kerridge, I., Lysaght, T., Munsie, M., Rudge, C., Stewart, C., Waldby, C. (2021). The Oversight of Clinical Innovation in a Medical Marketplace. In Graeme Laurie, Edward Dove, Agomoni Ganguli-Mitra, Catriona McMillan et al (Eds.), The Cambridge Handbook of Health Research Regulation, (pp. 287-295). Cambridge: Cambridge University Press. [More Information]

show 2 more

2020

Ghinea, N., Wiersma, M., Kerridge, I., Olver, I., Pearson, S., Day, R., Liauw, W., Lipworth, W. (2020). "Some sort of fantasy land": A qualitative investigation of appropriate prescribing in cancer care. Journal of Evaluation in Clinical Practice, 26(3), 747-754. [More Information]
Ghinea, N. (2020). A return to reasonableness and virtue in medical epistemology. Journal of Evaluation in Clinical Practice, 26(2), 447-451. [More Information]
Ghinea, N., Munsie, M., Rudge, C., Stewart, C. (2020). Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. Regenerative Medicine, 15(2), 1361-1369. [More Information]
Skowronski, G., O'Leary, M., Critchley, C., O'Reilly, L., Forlini, C., Ghinea, N., Sheahan, L., Stewart, C., Kerridge, I. (2020). Death, dying and donation: Community perceptions of brain death and their relationship to decisions regarding withdrawal of vital organ support and organ donation. Internal Medicine Journal, 50, 1192-1201. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2020). Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity? Journal of Bioethical Inquiry, 17(1), 87-94. [More Information]
De Carvalho Machado, G., Ghinea, N., Rogan, E., Day, R., Maher, C. (2020). Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines? EMA - Emergency Medicine Australasia, 32(5), 890-892. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2020). Lead Essay: Money, Equity and Access to Medicines. Journal of Bioethical Inquiry, 17(1), 25-27. [More Information]
Stewart, C., Kerridge, I., Waldby, C., Lipworth, W., Munsie, M., Lysaght, T., Rudge, C., Ghinea, N., Eckstein, L., Neilsen, J., et al (2020). Unconventional Practice, "Innovative" Interventions and the National Law. Journal of Law and Medicine, 27(3), 574-589.

show 5 more

2019

Ghinea, N. (2019). Citizen Science and the Politicization of Epistemology. The American Journal of Bioethics, 19(8), 58-60. [More Information]
Lipworth, W., Ghinea, N., Kerridge, I. (2019). Clarifying the Relationship Between Serious Ethical Violations and Conflicts of Interest. The American Journal of Bioethics, 19(1), 48-50. [More Information]
Lipworth, W., Kerridge, I., Ghinea, N., Zalcberg, J. (2019). Clearing the air: towards agreement about access to high cost cancer medicines. Annals of Oncology, 30(1), 143-146. [More Information]
Pace, J., Ghinea, N., Wiersma, M., Morrell, B., Kerridge, I., Lipworth, W. (2019). Clinical Quandaries Associated With Accelerated Access to Medicines. In Kathleen Montgomery, Wendy Lipworth (Eds.), Medical Professionals: Conflicts and Quandaries in Medical Practice, (pp. 48-66). New York: Routledge. [More Information]
Day, R., Cohen, M., Coleshill, M., Ghinea, N., Lipworth, W., Maher, C., Latimer, J., Lin, C., McLachlan, A. (2019). Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis? The Lancet, 1, e142. [More Information]
Wiersma, M., Ghinea, N., Lipworth, W. (2019). Limiting religious contributions - a response to Schuklenk. Developing World Bioethics, 19(3), 126-127. [More Information]
Ghinea, N., Kerridge, I., Lipworth, W. (2019). Off-Label Prescribing: The Borderlands Between Clinical Practice and Experimentation. In Kathleen Montgomery, Wendy Lipworth (Eds.), Medical Professionals: Conflicts and Quandaries in Medical Practice, (pp. 28-47). New York: Routledge. [More Information]
Wiersma, M., Ghinea, N., Kerridge, I., Lipworth, W. (2019). ‘Treat them into the grave’: cancer physicians’ attitudes towards the use of high-cost cancer medicines at the end of life. Sociology of Health & Illness, 41(2), 343-359. [More Information]

show 5 more

2018

Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2018). An ethical framework for the creation, governance and evaluation of accelerated access programs. Health Policy, 122(9), 984-990. [More Information]

2017

Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Accelerated Access to Medicines: An Ethical Analysis. Therapeutic Innovation and Regulatory Science, 51(2), 157-163. [More Information]
Ghinea, N., Little, M., Lipworth, W. (2017). Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake. Journal of Bioethical Inquiry, 14(3), 401-410. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Caution needed in introduction of provisional approvals for medicines. Internal Medicine Journal, 47(11), 1321-1324. [More Information]
Ghinea, N., Kerridge, I., Little, M., Lipworth, W. (2017). Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribing. Journal of Evaluation in Clinical Practice, 23(3), 574-581. [More Information]
Pace, J., Ghinea, N., Kerridge, I., Lipworth, W. (2017). Demands for access to new therapies: Are there alternatives to accelerated access? BMJ, 359, 1-4. [More Information]
Ghinea, N., Lipworth, W., Day, R., Hill, A., Dore, G., Danta, M. (2017). Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries. The Lancet, 389(10075), 1268-1272. [More Information]
Danta, M., Ghinea, N. (2017). The complex legal and ethical issues related to generic medications. Viral hepatitis: a case study. Journal of Virus Eradication, 3(2), 77-81.
Harper, C., Ghinea, N., Lipworth, W. (2017). The Right to Health: Implications for the Funding of Medicines in Australia. Journal of Law and Medicine, 24(3), 640-655.

show 5 more

2016

Ghinea, N., Lipworth, W. (2016). Affordable access to innovative cancer medicines - don't forget the prices. Medical Journal of Australia, 204(6), 214-215.e1. [More Information]
Lipworth, W., Ghinea, N., Kerridge, I. (2016). Negotiating limits to the funding of high cost cancer medicines. Cancer Forum, 40(2), 93-96. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2016). Propaganda or the cost of innovation? Challenging the high price of new drugs. BMJ, 352, 1-4. [More Information]

2015

Ghinea, N., Lipworth, W., Kerridge, I. (2015). Evidence, regulation and 'rational' prescribing: The case of gabapentin for neuropathic pain. Journal of Evaluation in Clinical Practice, 21(1), 28-33. [More Information]
Ghinea, N., Lipworth, W., Kerridge, I. (2015). Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable? Therapeutic Innovation and Regulatory Science, 49(3), 359-363. [More Information]
Ghinea, N., Lipworth, W., Little, J., Kerridge, I., Day, R. (2015). Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage. Developing World Bioethics, 15(1), 48-54. [More Information]
Day, R., Lipworth, W., Ghinea, N. (2015). The Ethics Around Drug Labels and Generic Medicines. Therapeutic Innovation and Regulatory Science, 49(3), 348-351. [More Information]

show 1 more

2014

Ghinea, N., Lipworth, W., Kerridge, I., Little, J., Day, R. (2014). Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. The Hastings Center Report, 44(2), 38-45. [More Information]

2012

Ghinea, N., Ghinea, N., Lipworth, W., Lipworth, W., Kerridge, I., Kerridge, I., Day, R., Day, R. (2012). No evidence or no alternative? Taking responsibility for off-label prescribing. Internal Medicine Journal, 42(3), 247-251. [More Information]

Page not found

Dr Narcyz Ghinea

Publications

By Type

By Year